Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) treatment of patients with Richters syndrome (RS), refractory prolymphocytic leukemia (PLL) or refractory non-Hodgkins lymphoma (NHL)
When loading and transporting, it should be handled with care to prevent damage to the packaging, moisture and heat
Notably, translational delivery is optimized by ex vivo pretreatment during CAR-T cell manufacturing (2-day exposure during activation) rather than systemic administration: in vivo pentanoate fails to enhance anti-PD-1 therapy, whereas ex vivo programming preserves its metabolic-epigenetic effects and avoids off-target immunosuppression (e.g., Treg induction, which is triggered by butyrate but not pentanoate) (108, 109)
BPC-157 demonstrates unique multi-system modulation across dopaminergic, serotonergic, glutamatergic, GABAergic, and nitric oxide systems simultaneously